摘要
Objective: To explore the mechanism of Buyang Huanwu Decoction (BHD) in treating early cerebral infarction. Methods: Seventy cases with early cerebral infarction were random ly divided into two groups. Chinese medicine group (CMG, n=35) was treated with BHD; western medicine group (WMG, n=35) was treated with hydroxyethyl starch injection and enteric coated aspirin tablets. The levels of endothelin (ET) and calcitonin gene related peptide (CGRP) in plasma before and after treatment and the results of clinical treatment were observed.Al so healthy subjects were used as the normal control. Results: The levels of ET before treatment in the two treated groups were significantly higher than that of the healthy subjects (P<0.001), and the levels of CGRP were significantly lower (P<0.001). After treatment the metabolic imbalance of ET and CGRP improved significantly in the two treated groups (P<0.001), but the ET and CGRP in CMG improved more obviously than those in WMG (P<0.01, P<0.05). The markedly effective and curative rate of CMG was higher than that of WMG (68.6% vs 31.4%; χ2=9.65, P<0.01). Conclusion: BHD could improve the metabolic imbalance of ET and CGRP in patients with early cerebral infarction and on the virtue of this m echanism it could be used to treat cerebral infarction
Objective: To explore the mechanism of Buyang Huanwu Decoction (BHD) in treating early cerebral infarction. Methods: Seventy cases with early cerebral infarction were random ly divided into two groups. Chinese medicine group (CMG, n=35) was treated with BHD; western medicine group (WMG, n=35) was treated with hydroxyethyl starch injection and enteric coated aspirin tablets. The levels of endothelin (ET) and calcitonin gene related peptide (CGRP) in plasma before and after treatment and the results of clinical treatment were observed.Al so healthy subjects were used as the normal control. Results: The levels of ET before treatment in the two treated groups were significantly higher than that of the healthy subjects (P<0.001), and the levels of CGRP were significantly lower (P<0.001). After treatment the metabolic imbalance of ET and CGRP improved significantly in the two treated groups (P<0.001), but the ET and CGRP in CMG improved more obviously than those in WMG (P<0.01, P<0.05). The markedly effective and curative rate of CMG was higher than that of WMG (68.6% vs 31.4%; χ2=9.65, P<0.01). Conclusion: BHD could improve the metabolic imbalance of ET and CGRP in patients with early cerebral infarction and on the virtue of this m echanism it could be used to treat cerebral infarction
